Table 1 Overview of included studies
First Author, Year | Study Design | Population Size (n = 1243) | Age | Outcomes Reported |
|---|---|---|---|---|
Chen, 2008 [15] | Case Series | 28 | 53 ± 26 | Reinfection Rate, HHS, LLD |
Dubin 2022 [16] | Retrospective Cohort Study | 1030 | 60 ± 3 | Reinfection Rate |
Huang, 2010 [17] | Case Series | 14 | 54.3 ± 25.3 | Reinfection Rate, MAP |
Poignard, 2011 [18] | Case Series | 20 | 25 ± 18 | Reinfection Rate, VAS |
Ye, 2023 [19] | Case Series | 90 | Male: 45.64 ± 12.15; Female: 66.29 ± 1.66 | Reinfection Rate, HHS, VAS, WOMAC, LLD, ROM |
Anagnostakos, 2016 [20] | Case Series | 16 | 59.7 ± 27.7 | Reinfection Rate |
Zeng, 2019 [21] | Case Series | 45 | 45.9 ± 22.1 | Reinfection Rate, HHS, VAS, WOMAC, MAP, SF-12, LLD, ROM |